Christopher Francis's most recent trade in Wave Life Sciences Ltd. was a trade of 151,000 Share Option (right to buy) done . Disclosure was reported to the exchange on Feb. 4, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Wave Life Sciences Ltd. | Christopher Francis | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 151,000 | 151,000 | - | - | Share Option (right to buy) | |
Wave Life Sciences Ltd. | Christopher Francis | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 25,000 | 25,000 (0%) | 0% | 0 | Ordinary Shares | |
Wave Life Sciences Ltd. | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.17 per share. | 08 Nov 2024 | 36,000 | 36,000 (0%) | 0% | 8.2 | 294,120 | Ordinary Shares |
Wave Life Sciences Ltd. | Christopher Francis | See Remarks | Sale of securities on an exchange or to another person at price $ 16.00 per share. | 08 Nov 2024 | 36,000 | 0 (0%) | 0% | 16 | 576,000 | Ordinary Shares |
Wave Life Sciences Ltd. | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2024 | 36,000 | 0 | - | - | Share Option (right to buy) | |
Wave Life Sciences Ltd. | Christopher Francis | See Remarks | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 16 Oct 2024 | 79,714 | 0 (0%) | 0% | 14 | 1,115,996 | Ordinary Shares |
Wave Life Sciences Ltd. | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Oct 2024 | 65,625 | 84,375 | - | - | Share Option (right to buy) | |
Wave Life Sciences Ltd. | Christopher Francis | See Remarks | Sale of securities on an exchange or to another person at price $ 13.75 per share. | 16 Oct 2024 | 65,625 | 0 (0%) | 0% | 13.8 | 902,344 | Ordinary Shares |
Wave Life Sciences Ltd. | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.14 per share. | 16 Oct 2024 | 65,625 | 65,625 (0%) | 0% | 3.1 | 206,063 | Ordinary Shares |
Wave Life Sciences Ltd. | Christopher Francis | See Remarks | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 16 Oct 2024 | 40,997 | 0 (0%) | 0% | 13 | 532,961 | Ordinary Shares |
Wave Life Sciences Ltd. | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Oct 2024 | 40,997 | 0 | - | - | Share Option (right to buy) | |
Wave Life Sciences Ltd. | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 16 Oct 2024 | 40,997 | 40,997 (0%) | 0% | 2.5 | 101,673 | Ordinary Shares |
Wave Life Sciences Ltd. | Christopher Francis | See Remarks | Sale of securities on an exchange or to another person at price $ 13.50 per share. | 16 Oct 2024 | 22,500 | 0 (0%) | 0% | 13.5 | 303,750 | Ordinary Shares |
Wave Life Sciences Ltd. | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.83 per share. | 16 Oct 2024 | 22,500 | 22,500 (0%) | 0% | 2.8 | 63,675 | Ordinary Shares |
Wave Life Sciences Ltd. | Christopher Francis | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Oct 2024 | 22,500 | 22,500 | - | - | Share Option (right to buy) | |
Wave Life Sciences Ltd. | Francis Christopher | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2024 | 286,400 | 286,400 | - | - | Share Option (right to buy) | |
Wave Life Sciences Ltd. | Christopher Francis | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 244,700 | 244,700 | - | - | Share Option (right to buy) | |
Wave Life Sciences Ltd. | Christopher Francis | See Remarks | Sale of securities on an exchange or to another person at price $ 4.03 per share. | 16 Feb 2023 | 10,258 | 79,714 (0%) | 0% | 4.0 | 41,340 | Ordinary Shares |
Wave Life Sciences Ltd. | Christopher Francis | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 45,000 | 45,000 | - | - | Share Option (right to buy) | |
Wave Life Sciences Ltd. | Christopher Francis | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2022 | 32,500 | 100,839 (0%) | 0% | 0 | Ordinary Shares | |
Wave Life Sciences Ltd. | Christopher Francis | See Remarks | Sale of securities on an exchange or to another person at price $ 1.72 per share. | 04 May 2022 | 10,867 | 89,972 (0%) | 0% | 1.7 | 18,691 | Ordinary Shares |
Wave Life Sciences Ltd. | Christopher Francis | See Remarks | Sale of securities on an exchange or to another person at price $ 2.31 per share. | 16 Feb 2022 | 10,123 | 68,339 (0%) | 0% | 2.3 | 23,384 | Ordinary Shares |
Wave Life Sciences Ltd. | Christopher Francis | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 150,000 | 150,000 | - | - | Share Option (right to buy) | |
Wave Life Sciences Ltd. | Christopher Francis | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 50,000 | 81,160 (0%) | 0% | 0 | Ordinary Shares | |
Wave Life Sciences Ltd. | Christopher Francis | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 50,000 | 50,000 | - | - | Share Option (right to buy) | |
Wave Life Sciences Ltd. | Christopher Francis | See Remarks | Sale of securities on an exchange or to another person at price $ 10.57 per share. | 01 Feb 2021 | 2,698 | 78,462 (0%) | 0% | 10.6 | 28,518 | Ordinary Shares |